米食品医薬品局(FDA)が磁性造影剤を用いた新しいセンチネルリンパ節生検を乳がんに対して承認【FDA】

FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer

 


The U.S. Food and Drug Administration today approved a magnetic device system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. The Magtrace and Sentimag Magnetic Localization System (Sentimag System) uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

 


 


 

コメント

Leave a comment

Your email address will not be published.


*